Company Profile
Professor-level R&D personnel, and marketing executives, the company boasts abundant industry resources. The company has currently established a marketing center and R&D office in Wuxi. Meanwhile, it invested nearly 30 million yuan in Changsha, Hunan, to build a production base — Changsha Dongdian Pharmaceutical Co., Ltd. — which obtained the national veterinary drug GMP certification in July 2024. Equipped with over 100 sets of the latest automated equipment, 5 automated assembly line workshops (all at Class D or higher purification level), and a traditional Chinese medicine extraction workshop, it can produce 17 dosage forms, including eye drops, eye ointments, oral solutions, oral pastes, external insecticides, liniments, sprays, external liquid preparations, non-chlorine disinfectants, external ointments, creams, ear creams, ear drops, tablets containing traditional Chinese medicine extracts (including soft chewable tablets), capsules, granules, dry suspensions, etc. The annual R&D investment accounts for 20% of the operating income, and the current contract amount of new veterinary drug projects under research exceeds 40 million yuan.
